Sodium Carbonate → HCID 67959840, compound
Reaction equation
Cl.Cl.Br[C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[NH:9][N:8]=[C:7]2[C:13]1[N:18]=[C:17]([N:19]2[CH2:24][CH2:23][CH:22]([NH2:25])[CH2:21][CH2:20]2)[CH:16]=[N:15][CH:14]=1.[CH:26]1([NH:29][C:30]([C:32]2[CH:33]=[CH:34][C:35]([F:41])=[C:36](B(O)O)[CH:37]=2)=[O:31])[CH2:28][CH2:27]1.C([O-])([O-])=O.[Na+].[Na+]>C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].O1CCOCC1>[NH2:25][CH:22]1[CH2:23][CH2:24][N:19]([C:17]2[N:18]=[C:13]([C:7]3[C:6]4[C:10](=[CH:11][CH:12]=[C:4]([C:34]5[CH:33]=[C:32]([CH:37]=[CH:36][C:35]=5[F:41])[C:30]([NH:29][CH:26]5[CH2:27][CH2:28]5)=[O:31])[CH:5]=4)[NH:9][N:8]=3)[CH:14]=[N:15][CH:16]=2)[CH2:20][CH2:21]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 80 °C
Procedure
To a 5 mL conical microwave vial was added Pd(dppf)Cl2 (15.53 mg, 0.02 mmol), 1-(6-(5-bromo-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine dihydrochloride salt (Example 1) (71 mg, 0.19 mmol), and 5-(cyclopropylcarbamoyl)-2-fluorophenylboronic acid (46.7 mg, 0.21 mmol), capped, degassed and backfilled with argon (3×). Dioxane (1.9 mL) and 2N Na2CO3 aqueous solution (0.2 mL, 0.48 mmol) were added. The reaction mixture was stirred at 80° C. for 16 h. After cooling to RT, the reaction mixtures were filtered before concentrating under reduced pressure. The crude reaction mixture was purified by preparative HPLC using water with 0.1% NH4OH and ACN with 0.1% NH4OH (Column: Phenomenex Gemini-NX C18 110 A 5 μm, 21×100 mm) to afford the title compound. MS (ESI, pos. ion) m/z: 472 (M+1).
Workup
- customcapped
- customdegassed
- temperatureAfter cooling to RT
- customthe reaction mixtures
- filtrationwere filtered
- concentrationbefore concentrating under reduced pressure
- customThe crude reaction mixture
- customwas purified by preparative HPLC
Sources & evidence
- ORD record
- ord-93d1ea00b5174afd80650fa2d1351087
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09090593B2
Reaction notes
Loading…